Search results
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 1 day agoRegeneron has released encouraging trial results for its multiple myeloma antibody, linvoseltamab....
How to Safely Discontinue Multiple Myeloma Maintenance Care
Medscape· 5 days agoNew research suggested that the key to safely discontinuing multiple myeloma maintenance therapy is...
Pfizer reports data from Phase II multiple myeloma treatment trial
Clinical Trials Arena via Yahoo Finance· 2 days agoPfizer has announced findings from the Phase II MagnetisMM-3 clinical trial of ELREXFIO...
'General Hospital' star John J York returns to work after 'aggressive' cancer treatment
Fox News via Yahoo News· 9 hours ago"General Hospital" star John York is ready to return to the show after undergoing bone marrow...
'General Hospital's John J. York Emotionally Talks Returning to Soap After Cancer Battle
ET Online via AOL· 1 day agoGeneral Hospital star John J. York became emotional while discussing his battle with cancer and the...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 5 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed ...
Soap star opens up about fighting 2 types of cancer
ABC News· 1 day agoHospital" star John York is opening up about his cancer treatment for the first time on "Good Morning America." York has been battling two forms of...
John J. York opens up about 'very welcoming' return to 'General Hospital' amid cancer battle
USA Today· 23 hours agoYork, who plays Mac Scorpio on the ABC soap opera, opened up about his emotional return to the series in an interview with "Good Morning America" on Monday. "Everybody has been very welcoming ...
Battling bureaucracy after burn pits: Why are contractors left behind?
Military Times via Yahoo News· 1 day agoIt was an unusual injury, doctors told him, so they ran some tests. Soon it made more sense. They...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 5 hours agoThe FDA accepted the company’s biologics license application (BLA) seeking accelerated approval for...